☆ 4.6 Letter

Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo

BRITISH JOURNAL OF DERMATOLOGY (2020)

Get Full Text
Add to Collection

Journal

BRITISH JOURNAL OF DERMATOLOGY
Volume 182, Issue 4, Pages 1047-1049

Publisher

WILEY
DOI: 10.1111/bjd.18606

Keywords

-

Categories

Dermatology

Funding

  1. National Institutes of Health [1R21AR07340801]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.